Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06986148 · ClinicalTrials.gov registry record · NA

Comparing Antibiotic Treatment Strategies for Children With Pneumonia in Outpatient Settings: (STAMPP)

A NA study of Community-acquired Pneumonia and Community Acquired Pneumonia (CAP), sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.

Recruiting
Registry status
NA
Development phase
2,000
Enrollment target
4
Study locations

NCT06986148: Recruiting NA study of Community-acquired Pneumonia and Community Acquired Pneumonia (CAP), sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.

NCT06986148 is a NA study of Community-acquired Pneumonia and Community Acquired Pneumonia (CAP) that is actively recruiting participants, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 2,000 participants, below the 108,899-participant average among 9 other Community-acquired Pneumonia trials with a reported enrollment target (98% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06986148, a NA study of Community-acquired Pneumonia and Community Acquired Pneumonia (CAP), is actively recruiting participants, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.

RECRUITING
Registry status
NA
Development phase
2,000 participants
Enrollment target
4
Study locations

Study Summary

The goal of this clinical trial is to determine if a "watch and wait" antibiotic strategy, called Safety Net Antibiotic Prescribing (SNAP), can safely reduce unnecessary antibiotic use while ensuring that children diagnosed with community-acquired pneumonia get better from their illness. The main aims of this study are: * To compare the effectiveness of SNAP versus immediate antibiotic prescribing in children with mild community-acquired pneumonia (CAP) * To identify which patient groups benefit most from the SNAP strategy * To identify factors that shape implementation of each prescribing strategy. Researchers will compare the SNAP strategy (where parents or guardians are instructed to give antibiotics only if their child is not improving after 72 hours, or sooner if they are worsening) to the immediate antibiotic prescribing strategy (where parents or guardians are instructed to give the antibiotics right after their healthcare visit) to see if one strategy is more effective than the other. Participants will be randomly assigned to either the immediate antibiotic group or the SNAP group at enrollment. Participation lasts 14 days with follow-up surveys at 4, 7, and 14 days after enrollment.

Primary Outcome

Clinical improvement at 7 days after the index visit, defined as parent-reported (a) perception of overall improvement, (b) no worsening of fever, work of breathing, concerning changes in activity, or decreased oral intake, (c) no new antibiotic use or hospitalization following the index visit, and (d) improvement in at least one key pneumonia symptom in (b).

Interventions

  • OTHER Immediate Antibiotic Prescribing Group Instructions
  • OTHER Safety Net Antibiotic Prescribing (SNAP) Group Instructions

Study Locations (4)

Georgia

  • Children's Healthcare of Atlanta - Atlanta

Illinois

  • Ann & Robert H. Lurie Children's Hospital of Chicago - Chicago

Pennsylvania

  • Children's Hospital of Philadelphia - Philadelphia

Utah

  • Primary Children's Hospital - Salt Lake City

Trial Details

FieldValue
Enrollment Target 2,000 participants
Start Date 2025-09-09
Est. Completion 2029-07-16
Phase NA

What NCT06986148 shows while recruiting

NCT06986148 is an interventional study that assigns participants to a tested intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, below the 108,899-participant average among 9 other Community-acquired Pneumonia trials with a reported enrollment target (98% lower).

The record links to 2 conditions, with Community-acquired Pneumonia appearing as the primary indexed condition, and to 2 interventions - of which Immediate Antibiotic Prescribing Group Instructions is the first listed.

NCT06986148 reports a single indexed study location in Georgia, Illinois, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06986148 about?

NCT06986148 is a clinical study titled "Comparing Antibiotic Treatment Strategies for Children With Pneumonia in Outpatient Settings: (STAMPP)". The goal of this clinical trial is to determine if a "watch and wait" antibiotic strategy, called Safety Net Antibiotic Prescribing (SNAP), can safely reduce unnecessary antibiotic use while ensuring that children diagnosed with community-acquired pneumonia get better from their illness. The main ai...

What is the current status of trial NCT06986148?

This trial is currently recruiting. It is a NA study. The enrollment target is 2,000 participants. The study started on 2025-09-09. Estimated completion is 2029-07-16.

What conditions does trial NCT06986148 study?

This clinical trial studies the following conditions: Community-acquired Pneumonia, Community Acquired Pneumonia (CAP).

What interventions are being tested in trial NCT06986148?

The interventions under investigation include: Immediate Antibiotic Prescribing Group Instructions (OTHER), Safety Net Antibiotic Prescribing (SNAP) Group Instructions (OTHER).

Who is sponsoring clinical trial NCT06986148?

This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06986148 being conducted?

This trial has 4 study locations across Georgia, Illinois, Pennsylvania, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Community-acquired Pneumonia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06986148's enrollment target sits among peer trials

2,000 4th of 9 higher than 6 of 9 other Community-acquired Pneumonia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Community-acquired Pneumonia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001465 · 2,000 participants

    Study of the Disease Process of Lymphangioleiomyomatosis

  • NCT00001595 · 2,000 participants

    An Investigation of Pituitary Tumors and Related Hypothalmic Disorders

  • NCT00138931 · 2,000 participants

    Genetics of Cardiovascular and Neuromuscular Disease

  • NCT00288119 · 2,000 participants

    Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06986148, the US trial registry maintained by the National Library of Medicine. NCT06986148 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.